OA10894A - Médicament optimisant la viscosité des mucus et stimulant le fonctionnement de l'intestin - Google Patents

Médicament optimisant la viscosité des mucus et stimulant le fonctionnement de l'intestin Download PDF

Info

Publication number
OA10894A
OA10894A OA9800190A OA9800190A OA10894A OA 10894 A OA10894 A OA 10894A OA 9800190 A OA9800190 A OA 9800190A OA 9800190 A OA9800190 A OA 9800190A OA 10894 A OA10894 A OA 10894A
Authority
OA
OAPI
Prior art keywords
proteinase
panstimase
exocellular
manufacture
medicament
Prior art date
Application number
OA9800190A
Other languages
English (en)
French (fr)
Inventor
Michel Hooreman
Original Assignee
Michel Hooreman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michel Hooreman filed Critical Michel Hooreman
Publication of OA10894A publication Critical patent/OA10894A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
OA9800190A 1996-04-05 1998-10-05 Médicament optimisant la viscosité des mucus et stimulant le fonctionnement de l'intestin OA10894A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9604310A FR2747045B1 (fr) 1996-04-05 1996-04-05 Nouveau medicament optimisant la viscosite des mucus et ameliorant le fonctionnement de l'intestin

Publications (1)

Publication Number Publication Date
OA10894A true OA10894A (fr) 2003-02-21

Family

ID=9490963

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9800190A OA10894A (fr) 1996-04-05 1998-10-05 Médicament optimisant la viscosité des mucus et stimulant le fonctionnement de l'intestin

Country Status (18)

Country Link
US (1) US6440413B1 (zh)
EP (1) EP0891189A1 (zh)
JP (1) JP4196225B2 (zh)
CN (1) CN1168499C (zh)
AP (1) AP1018A (zh)
AU (1) AU735340B2 (zh)
BR (1) BR9708506A (zh)
CA (1) CA2251009C (zh)
CZ (1) CZ298428B6 (zh)
FR (1) FR2747045B1 (zh)
HU (1) HUP9902421A3 (zh)
NO (1) NO324877B1 (zh)
NZ (1) NZ332107A (zh)
OA (1) OA10894A (zh)
PL (1) PL188157B1 (zh)
RU (1) RU2198673C2 (zh)
TR (1) TR199801976T2 (zh)
WO (1) WO1997037681A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041296B1 (en) * 1999-11-12 2006-05-09 The United States Of America As Represented By The Department Of Health And Human Services Methods of treating inflammatory bowel disease using cholera toxin B subunit
DE602005022187D1 (de) * 2004-05-24 2010-08-19 Novozymes As Enzyme für pharmazeutische anwendung
GB2430881B (en) * 2005-10-06 2010-10-13 Ntnu Technology Transfer As Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
GB0707096D0 (en) 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
US8455235B2 (en) 2007-12-04 2013-06-04 Novozymes A/S Protease variants for pharmaceutical use
GB0904942D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
GB0904941D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
FR2998450A1 (fr) * 2012-11-26 2014-05-30 Dominique Hooreman Utilisation d'un complexe enzymatique dans l'alimentation des animaux d'elevage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1133579A (en) * 1966-03-09 1968-11-13 Shionogi & Co Process for preparing proteases and enzymatic composition prepared thereby
FR2600340A1 (fr) * 1986-06-20 1987-12-24 Hooremam Michel Procede de production d'un nouveau complexe proteolytique stimulant l'activite du pancreas et ses applications en zootechnie

Also Published As

Publication number Publication date
WO1997037681A1 (fr) 1997-10-16
AU2393897A (en) 1997-10-29
CA2251009A1 (fr) 1997-10-16
CN1168499C (zh) 2004-09-29
CZ298428B6 (cs) 2007-10-03
PL329161A1 (en) 1999-03-15
JP2000509025A (ja) 2000-07-18
NO984632D0 (no) 1998-10-02
NO984632L (no) 1998-12-03
NZ332107A (en) 2001-10-26
PL188157B1 (pl) 2004-12-31
CZ318598A3 (cs) 1999-05-12
JP4196225B2 (ja) 2008-12-17
BR9708506A (pt) 1999-08-03
FR2747045B1 (fr) 1998-06-26
EP0891189A1 (fr) 1999-01-20
TR199801976T2 (xx) 2000-10-23
AU735340B2 (en) 2001-07-05
RU2198673C2 (ru) 2003-02-20
AP9801357A0 (en) 1998-12-31
US6440413B1 (en) 2002-08-27
HUP9902421A2 (hu) 1999-11-29
CN1221347A (zh) 1999-06-30
FR2747045A1 (fr) 1997-10-10
AP1018A (en) 2001-10-15
HUP9902421A3 (en) 2001-05-28
CA2251009C (fr) 2013-07-02
NO324877B1 (no) 2007-12-27

Similar Documents

Publication Publication Date Title
CN1035801C (zh) 对动物肠部释放生物活性物质的微粒制剂的制备方法
JP2000509367A (ja) ヘリコバクタピロリ感染の治療用医薬を製造するためのラクトペルオキシダーゼ、ペルオキシドドナーおよびチオシアネートの使用
PT1261368E (pt) COMPOSIÃO CONTENDO UMA LIPASE NO FUNGICA, COM LIGAÃŽES CRUZADAS, E MéTODOS PARA A SUA PREPARAÆO
JPH0587052B2 (zh)
JP2001526690A (ja) シュウ酸塩関連疾患を予防するためのシュウ酸塩分解微生物またはシュウ酸塩分解酵素
CA2251009C (fr) Medicament optimisant la viscosite des mucus et stimulant le fonctionnement de l'intestin
TWI291351B (en) Pharmaceutical composition for lowering blood-sugar
BE1005641A3 (fr) Composition vegetale de faible poids moleculaire et sa preparation.
SE454566B (sv) Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus
CN105999231A (zh) 一种多肽组合物、提高畜禽免疫功能的组合物、制备方法
WO1989006970A1 (en) Lipid metabolism improving agent and method of its use
FR2813084A1 (fr) Preparation de bacteries lactiques ayant une activite de biopurification
CN106573034B (zh) 海洋肽和鱼核苷酸、组合物及其用于降低血糖的用途
JP3979543B2 (ja) 抗アレルギー剤及びその製造法
JP5916051B2 (ja) 抗炎症剤および抗炎症剤の製造方法
KR100563523B1 (ko) 점액점도를최적화시키고,장의기능을자극하기위한약제
FR3017536A1 (fr) Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
JP2001340055A (ja) 家畜、家禽類給餌方法および給餌用人工乳組成物
MXPA98008200A (en) Medication that optimizes the viscous of the moco and which stimulates the functioning of intest
JP4695629B2 (ja) 難消化剤
JP2001002576A (ja) 体重増加抑制剤
CH644632A5 (en) Bacterial culture medium, process for preparing it and use of this medium
TWI283268B (en) Novel microorganism strain GM-020 of Lactobacillus rhamnosus and its use for treating obesity
RU2353374C1 (ru) Способ лечения диареи у сельскохозяйственных животных
Konantz A new digestant